Treatment With Direct-Acting Antivirals Tied To Improved Outcomes, Long-Term Survival Among Patients With Chronic HCV, Study Finds
				
				December 14, 2022
				
					MedPage Today (12/13, Hein) reports, “Treatment with direct-acting antivirals (DAA) was associated with improved outcomes as well as improved long-term survival among patients with chronic hepatitis C,” according to findings from a “retrospective cohort s...